Abstract: Multiple sclerosis (MS) is a chronic disease often causing progressive debilitation for nearly one million Americans. Novel therapies exist that can help slow disease progression and limit new symptoms. Without assistance from support services, MS patients face significant challenges in accessing, affording and adhering to these complex, specialty medications. This report describes major barriers keeping MS patients from needed therapies along with inefficiencies of the traditional model for patient access and support services that suppress enrollment and delay time to therapy. A new technological innovation from CoverMyMeds that solves for these specialty access and support problems is introduced.